Anti-VEGF Drugs in Eye Diseases: Local Therapy with Potential Systemic Effects

By  

Current Pharmaceutical Design, Vol. 21, Iss. 24, 2015-01 ,pp. : 3548-3556

Bentham Science Publishers

Access to resources Recommend Favorite

Resistance to Anti-VEGF Agents

By  

Current Pharmaceutical Design, Vol. 10, Iss. 1, 2004-01 ,pp. : 51-64

Bentham Science Publishers

Access to resources Recommend Favorite

Predicting Efficacy and Toxicity in the Era of Targeted Therapy: Focus on Anti-EGFR and Anti-VEGF Molecules

By  

Current Drug Metabolism, Vol. 12, Iss. 10, 2011-12 ,pp. : 944-955

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-VEGF Treatment of Corneal Neovascularization

By Keating Anne M.   Jacobs Deborah S.  

The Ocular Surface, Vol. 9, Iss. 4, 2011-10 ,pp. : 227-238

Ethis Communications

Access to resources Recommend Favorite

Aflibercept (VEGF-TRAP): The Next Anti-VEGF Drug

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 10, Iss. 6, 2011-12 ,pp. : 497-508

Bentham Science Publishers

Access to resources Recommend Favorite